Randomised multicentre phase III study comparing weekly versus every-3-week carboplatin plus paclitaxel in patients with advanced ovarian cancer: the MITO-7 (Multicentre Italian Trials in Ovarian cancer) -ENGOT-OV-10 (European Network of Gynaecological Oncological Trial Groups) -GCIG (Gynecologic Cancer InterGroup) trial.